infantile hemangioma
Conditions
Interventions
Infantile Hemangioma Group Treated with Oral Propranolol:None
Control groupe:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
0.2 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria for Infants with Hemangiomas Treated with Oral Propranolol: 1. Meet the clinical diagnostic and treatment criteria requiring oral propranolol therapy for infantile hemangiomas; 2.Have not taken any neurological or psychiatric medications affecting sleep within the past 6 months; 3. Legal guardian consents to participate in this study. Inclusion Criteria for the Control Group: 1. Infants who do not require oral propranolol treatment for hemangiomas; 2. No sleep disorders or other neurological or psychiatric diseases; 3. Have not taken any neurological or psychiatric medications affecting sleep within the past 6 months; 4. Legal guardian consents to participate in this study.
Exclusion criteria
Exclusion criteria: Exclusion Criteria for Participants: 1. History of other severe psychiatric disorders, such as schizophrenia; 2. History of other confirmed organic brain diseases, such as epilepsy, traumatic brain injury, encephalitis, etc.; 3. Presence of intracranial metal implants or implanted medical devices (e.g., pacemakers); 4. Diagnosis of confirmed genetic or metabolic disorders, such as Down syndrome, Fragile X syndrome, Angelman syndrome, etc.; 5. Currently taking neurological or psychiatric medications that affect sleep, or having discontinued such medications for less than six months; 6. Inability to cooperate with polysomnography (PSG) monitoring.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep Monitoring;Denver Developmental Screening Test II; | — |
Secondary
| Measure | Time frame |
|---|---|
| Infant Sleep Habits Questionnaire;World Health Organization Infant and Toddler Developmental Assessment Tool;Mullen Scales of Early Learning;Assessment of brain function; | — |
Countries
China
Contacts
Public ContactYanan Li
West China Hospital of Sichuan University
Outcome results
None listed